Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    17239478 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Adefovir and Lamivudine for Entecavir Resistance (ALTER Study)
Condition: Chronic Hepatitis B
Intervention: Drug: ADEFOVIR, LAMIVUDINE

Indicates status has not been verified in more than two years